Sponsor:
Alliance for Clinical Trials in Oncology
Code:
NCT07215910
Conditions
Astrocytoma, IDH-Mutant, Grade 3
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Intensity-Modulated Radiation Therapy
Volume Modulated Arc Therapy
Pencil Beam Scanning
Intensity-Modulated Proton Therapy
Temozolomide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-20. This information was provided to ClinicalTrials.gov by Alliance for Clinical Trials in Oncology on 2026-06-16.